Samsung's Ontruzant Becomes First Trastuzumab Biosimilar Approved In EU

 
• By Jung Won Shin
  
Samsung Bioepis
Samsung Bioepis researchers conducting a study • Source: Samsung Bioepis
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip